Bortezomib-associated fatal liver failure in a haemodialysis patient with multiple myeloma

Clinical Toxicology

Volumn 50, Issue 5, 2012, Pages 444-445

  Cornelis, Tom ^a   Beckers, Erik A M ^a   Driessen, Ann L C ^a   Van Der Sande, Frank M ^a   Koek, Ger H ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Dialysis; Liver; Other

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; BORTEZOMIB; DEXAMETHASONE; IBUPROFEN;

AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BONE MARROW BIOPSY; BONE PAIN; CASE REPORT; CHOLESTATIC HEPATITIS; FIBROSING ALVEOLITIS; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; HYPERCALCEMIA; HYPERTENSION; HYPOXIC ISCHEMIC ENCEPHALOPATHY; JAUNDICE; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY FAILURE; LIVER FAILURE; LOW DRUG DOSE; MALE; MULTIPLE MYELOMA; PROTEINURIA;

AGED; ANTINEOPLASTIC AGENTS; BORONIC ACIDS; CHOLESTASIS; DRUG-INDUCED LIVER INJURY; FATAL OUTCOME; HUMANS; LIVER FAILURE; MALE; MULTIPLE MYELOMA; PYRAZINES; RENAL DIALYSIS;

EID: 84861063166     PISSN: 15563650     EISSN: 15569519     Source Type: Journal    
DOI: 10.3109/15563650.2012.673624     Document Type: Article

References (5)

1. Richardson PG, Barlogie B, Berenson J, Singhal S, Jagannath S, Irwin D, et al. A phase 2 study of bortezomib in relapsed refractory myeloma. N Engl J Med 2003; 348:2609-2617.
2. Rosin ol L, Montoto S, Cibeira MT, Bladé J. Bortezomib-induced severe hepatitis in multiple myeloma. Arch Intern Med 2005; 165: 464-465.
3. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, Janecek E, Domecq C, Greenblatt DJ. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30:239-245.
4. Edwards IR, Aronson JK. Adverse drug reactions. Lancet 2000; 356: 1255-1259.
5. Palumbo A, Bringhen S, Ludwig H, Dimopoulos MA, Bladé J, Mateos MV, et al. Personalized therapy in multiple myeloma according to patient age and vulnerability: A report of the European Myeloma Network (EMN). Blood 2011; 118:4519-4529.